Isho-ho was used to successfully treat three cases of muscular weakness. The first case was a 59-year-old woman. In May of 1993, she began to suffer from a feeling of general lethargy. The condition was diagnosed as multiple myositis, and prednisolone was administered. However, since she still experienced loss of strength in the lower limbs, she was introduced to the authors' department for treatment in August of 1994. Administration of Isho-ho improved the loss of strength in the lower limbs and increased her grip strength.
The second case was a 42-year-old woman who complained of unusual sensations in the tips of her fingers and toes starting in mid-September, 1994. In November of the same year, she began to experience a loss of strength in the limbs. In February of 1995, the condition was diagnosed as chronic inflammatory demyelinatory multiple neuropathy by the same department, and large doses of steroids were administered. Although this treatment delayed the loss of strength in the lower back and legs, actual improvement in the condition did not occur until Isho-ho was given.
The third case involved a 63-year-old man who began to experience a loss of strength in the lower limbs in 1984. In 1988, the loss of strength became pronounced. In June of the same year, he sought treatment at the authors' department, and the condition was diagnosed as bulbar myelinic muscular atrophy. In October of 1993, he was unable to get out of bed unassisted, and was admitted to the authors' department. He was given Isho-ho, and reported a decrease in the feeling of a loss of strength in the lower limbs, and a disappearance of greater pectoral muscle spasms. These results suggest that Isho-ho is not only effective for loss of strength in the lower limbs, but may also be efficacious for loss of strength, numbness and muscle spasms in the upper limbs.

Keishi-kyokei-ka-bukuryo-byakujutsu-to has been traditionally used for acute infectious diseases, such as the common cold, accompanied by epigastric discomfort and tenderness. However, the specific dosage for chronic diseases has not been clearly set yet. This study involved 4 cases with headaches, dull headaches, stiff shoulders and lumbago, so called neck, shoulder and arm syndrome which responded to Keishi-kyokei-kabukuryo-byakujutsu-to. The experience of these cases suggests that conditions indicating Keishi-kyokei-kabukuryo-byakujutsu-to have the following features: (1) dry skin, (2) edema and impressions of teeth at the rim of the tongue, (3) tenderness upon pressure in the epigastric region and sound of fluctuating liquid in the stomach, (4) Ki-deficiency.

We report a case of rheumatoid arthritis (RA) that showed improvement after treatment with Daiseiryu-to-kadaiou. The patient was a 77-year-old woman diagnosed with RA in 1988. She had been visiting our department regularly since 1994. Oral steroids were used for two weeks in May 1994, but were discontinued due to a bacterial infection of the artificial femoral head. Thereafter, treatment was continued with bucillamine, nonsteroidal anti-inflammatory drugs, and various Kampo medicines. Joint pain worsened in November 2001. She was hospitalized on **********, as the CRP level had elevated to 15.2mg/dl. She had been taking bucillamine for seven years, but it had already been assessed as ineffective. It was discontinued upon hospitalization, and treatment with Daiseiryu-to-kadaiou was immediately begun. By ******, the patient judged the pain in both knees to have improved by about 50 percent. Moreover, the CRP level decreased to 2.4mg/dl by *******. The Lansbury index also improved from 100 percent to 69 percent during her hospitalization, and she was discharged on *******. Based on this experience, it is suggested that the prescription of Daiseiryu-to-kadaiou be considered in the treatment of RA patients.

We report two cases of ulcerative colitis successfully treated with Kigi-kenchu-to. Case One was a 35-year-old male. He had been diagnosed with ulcerative colitis at another hospital, had been receiving corticosteroid (prednisolone) treatment, but his symptoms (abdominal pain, diarrhea and hematochezia) improved little. He visited our department and was admitted. Treatment with Kigi-kenchu-to for 2 weeks improved his symptoms and colonoscopic findings, and he was discharged.
Case Two was a 28-year-old female. She had been diagnosed with ulcerative colitis at another hospital. She had received modern medicinal treatments, including steroid pulse therapy and granulocytapheresis for 10 years. But her symptoms (abdominal pain, diarrhea and hematochezia more than 10 times a day) showed little improvement. She visited our department, and Kampo treatment with Kigi-kenchu-to-ka-gaiyo-akyo was begun. After 4 weeks, her symptoms and colonoscopic results had improved. Based on these experiences, it is suggested that Kigi-kenchu-to might be an effective formulation in the treatment of ulcerative colitis.

We report two cases of ankylosing spondylitis (AS) successfully treated with Kampo formulae including Uzu (aconiti tuber). The 1st case was a 33-year-old male. Since the age of 20, he had stiffness and pain in his back. At 26 years of age, he was diagnosed with AS by a nearby orthopedist. When he consulted our department in 1997, X-ray examination revealed a Bamboo spine appearance. Because coldness exacerbated the pain, we prescribed Uzu-to. Together with a decrease in inflammatory reaction, his pain and quality of life were improved. The 2nd case was a 24-year-old male. He had left hip joint pain since the age of 14, and at 16 was diagnosed with AS and treated with NSAIDs. Methotrexate (MTX) had also been prescribed from the age of 23, since the pain of other joints and back was gradually progressive with consistently positive inflammation. He did not, however, improve on MTX, and visited our department in 2002. His HLA-B27 was positive, while iliosacral arthritis was also noted. Uzukeishi-to was then prescribed, resulting in decreased pain, alleviation of restricted motion, and an improved inflammation reaction. This suggests that Kampo formulae which include Uzu may be useful in the treatment of AS.

We report a case of a patient with steroid-dependent nephrotic syndrome, who achieved complete remission with a combination of steroid therapy and Bunsho-to. The patient was a 27-year-old female who became aware of edema, and was diagnosed as suffering from focal glomerular sclerosis (glomerulosclerosis) with nephrotic syndrome in November 1992. She responded to steroid therapy, but nephrotic syndrome relapsed frequently after the repeated reduction of steroids. In July 1995, she came to our hospital, and was diagnosed as having a recurrence of nephrotic syndrome. Although the combination therapy of steroid and Kampo formulas, Shinbu-to or Shimotsu-to and/or Keigairengyo-to, was effective, an exacerbation of nephrotic syndrome occurred after steroid therapy was discontinued, in July 1997. The prescription was changed to Bunsho-to, and steroid therapy was re-initiated with 10mg of prednisolone daily. As a result, she achieved complete remission. The steroid therapy could be discontinued in July 1999, and now she has taken Bunsho-to only for 18 months. But the complete remission of nephrotic syndrome has been maintained.

A pregnant woman suffering from subchorionic hematoma (which had not responded to any Western medicine) was in danger of having a miscarriage. She was treated successfully with Shimi-kyogai-to-kami. When she was in the tenth week of pregnancy, lower abdominal pain and genital bleeding started and continued despite the administration of carbazochrome sodium sulfonate, tranexamic acid and ritodrine hydrochloride. We initiated Shimi-kyogai-to-kami in the 17th week of the pregnancy, and her symptoms improved within four weeks. The hematoma disappeared in less than five weeks. She made satisfactory progress without recurrence and gave birth to a baby boy weighing 2628g in the 37th week of the pregnancy. It is possible that therapy based on Kampo diagnosis is useful in the treatment of subchorionic hematoma. Moreover, it seems that Shimi-kyogai-to is safer than Kyuki-kyogai-to in the treatment of pregnant women.

Three cases of dermatosis successfully treated with modified Mao-rensho-shakushozu-to are reported. Case 1 was a 45-year-old male who had been suffering from atopic dermatitis since childhood. He came to our clinic for treatment with Kampo formulas for unchanging symptoms. At first we prescribed Mao-rensho-shakushozu-to-go-byakko-ka-keishi-to, but this formula was not effective. After prescribing Mao-rensho-shakushozu-to-go-eppi-ka-jutsu-to, the dermatitis improved. Case 2 was a 25-year-old male student who had been suffering from atopic dermatitis since he was 19 years old. He responded to steroid ointment, but relapsed frequently after the repeated reduction of steroids. Some Kampo formulas were not effective, but the dermatitis improved after the patient used Mao-rensho-shakushozu-to-go-eppi-ka jutsu-to. Case 3 was a 65-year-old male who had been suffering from psoriasis vulgaris since he was 57. Shakushozu-to-go-byakko-ka-ninjin-to was effective for his psoriasis.
We used modified Mao-rensho-shakushozu-to in the three cases described above be cause the patients had strong itching. It is possible to apply this Kampo formula for dermatitis with strong itching.

Kumi-binro-to is a Kampo formulation produced by Sohaku Asada. It has been used for patients with stasis of body fluids presenting beriberi-like symptoms. The cases in this report where Kumi-binro-to was effective had symptoms similar to the cases where it was ineffective, but they had different distributions of tympanic sound in the abdomen.
We investigated the efficacy of four weeks of treatment with Kumi-binro-to in 30 cases having both symptoms of stasis of body fluids and tympanic sound in the abdomen. Kumi-binro-to was effective in 20 of 25 cases that had the tympanic sound in the right iliac, flank and subphrenic regions. However, Kumi-binro-to was not effective in 5 cases where the tympanic sound was restricted to the epigastrium, left iliac, flank and subphrenic regions. Tympanic sound on the right side of the abdomen might be one of the indications for Kumi-binro-to.

We report a case of a man with lower extremity cellulitis, who had not responded to a two-week treatment with cefditoren, being successfully treated with Ji-daboku-ippo.
A 29-year-old man underwent an operation of the left knee six months earlier, and progress was good. However, his left lower extremity developed cellulitis. Cefditoren was administered, but it was not effective. We administered Ji-daboku-ippo, and his symptoms improved within three days and laboratory data improved within one week. We consider that therapy based on Kampo diagnosis is useful in the treatment of postoperative cellulitis on extremities.